SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19097079
Source:
http://linkedlifedata.com/resource/pubmed/id/19097079
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011923
,
umls-concept:C0023884
,
umls-concept:C0036043
,
umls-concept:C1261322
,
umls-concept:C1613998
pubmed:issue
1
pubmed:dateCreated
2008-12-24
pubmed:abstractText
To prospectively investigate, by means of a pre-and postexamination questionnaire, the types and frequency of adverse reactions to ferucarbotran (Resovist), a superparamagnetic iron oxide (SPIO) contrast agent.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9105850
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Dextrans
,
http://linkedlifedata.com/resource/pubmed/chemical/Ferumoxytol
,
http://linkedlifedata.com/resource/pubmed/chemical/Iron
,
http://linkedlifedata.com/resource/pubmed/chemical/Magnetite Nanoparticles
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxides
,
http://linkedlifedata.com/resource/pubmed/chemical/ferumoxides
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1053-1807
pubmed:author
pubmed-author:HirohashiShinjiS
,
pubmed-author:HoriMasatoshiM
,
pubmed-author:ImaiYasuharuY
,
pubmed-author:KimTonsokT
,
pubmed-author:MatsukiMitsuruM
,
pubmed-author:MurakamiTakamichiT
,
pubmed-author:NakamuraHironobuH
,
pubmed-author:NarumiYoshifumiY
,
pubmed-author:OnishiHiromitsuH
,
pubmed-author:SakuraiKousukeK
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
106-11
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19097079-Aged
,
pubmed-meshheading:19097079-Dextrans
,
pubmed-meshheading:19097079-Dizziness
,
pubmed-meshheading:19097079-Ferumoxytol
,
pubmed-meshheading:19097079-Humans
,
pubmed-meshheading:19097079-Iron
,
pubmed-meshheading:19097079-Japan
,
pubmed-meshheading:19097079-Liver
,
pubmed-meshheading:19097079-Liver Diseases
,
pubmed-meshheading:19097079-Magnetite Nanoparticles
,
pubmed-meshheading:19097079-Nausea
,
pubmed-meshheading:19097079-Oxides
,
pubmed-meshheading:19097079-Questionnaires
,
pubmed-meshheading:19097079-Risk Assessment
,
pubmed-meshheading:19097079-Vomiting
pubmed:year
2009
pubmed:articleTitle
Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation.
pubmed:affiliation
Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan.
pubmed:publicationType
Journal Article
,
Multicenter Study